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Abstract
Background: Low retention rates threaten the validity of clinical research studies and
generalizability of the results.
Aims: To survey Hepatitis B Research Network (HBRN) Cohort Study participants to evaluate
University of Michigan retention strategies, to develop best practices, and to identify other
strategies that will improve retention.
Methods: 90 patients that are currently participating in the HBRN Cohort study at the University
of Michigan were surveyed.
Results: Participants were a good mix of male (51.2%) and female (46.5%), mostly nonHispanic, between the age of 40 and 60 years (50%). Roughly half were Asian Chinese (50.2%),
had some graduate school education or a professional degree (54.7%), and an annual income of
more than $100,000 (45.4%). All the participants had medical insurance (private 87.2% vs.
government 12.8%). Average participation in the study was 3.95 years. 22.1% of the participants
reported they had missed at least one study visit and the main reason was they forgot the
appointment. Participants reported that no co-pay to see the specialists is a better motivating
factor than receiving financial compensation for staying in the study (38.4% vs. 18.6%).
Participants reported that the overall experience at the visit was the main motivating factor for
them to stay in the study. Eighty-nine % of participants responded they are likely to stay in the
study that is currently projected to end in late 2019 and moving away from the study site is the
main reason why they would discontinue participation in the study.
Conclusion: Overall, participants in the HBRN study seem to be satisfied with how the study is
being conducted at our site and willing to stay in the study until 2019, but the results did help us
identify a few areas for improvement.
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Chapter 1: Introduction
A longitudinal observational study is a study that involves repeated observations of the same
subjects over long periods of time and in which the investigators do not seek to intervene, only
observe the course of events. Longitudinal studies are designed to examine associations between
exposure to known or suspected causes of disease and subsequent morbidity or mortality (Coggon,
Rose, & Barker, 2003). Since the first requirement of most longitudinal studies is the identification of
the individuals forming the study group, longitudinal studies in epidemiology are usually referred to
as cohort studies (Breslow et al., 1987).
Though cohort studies are complex to organize and expensive to conduct, longitudinal cohort
studies remain important as many outcome variables can be examined in a single study and
sometimes they are the only methods available (Mann, 2003). Well-characterized cohorts permit
calculation of the effect of each variable on the probability of developing the outcome of interest.
However, the validity of results from cohort studies can be severely compromised if the recruitment
is low, if there is systematic bias in enrollment, or if there is a significant loss to follow-up of study
participants with time.
Low retention rates in a study threaten the internal and external validity of a study (Amico,
2009). The study results may be biased by differential dropout between comparison groups or by
differences in characteristics or outcomes between those participants who drop out and those that
continue to participate. Low retention rates also threaten the generalizability of the results of a study
and its statistical power (Friedman, Furberg, & DeMets, 2010; Szklo & Nieto, 2014).
Loss of patients over time is a common occurrence in prospective cohort studies due to subject
relocation, loss of interest in the study, inconvenience of having to travel to study site for visits, lack
of transportation, interference with work or family responsibilities, financial burden (transportation
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for study visits, cost for standard of care evaluations and tests, lost wages due to time off work, child
care), and poor rapport with study team (McSweeney, Pettey, Fischer, & Spellman, 2009; Nicholson
et al., 2011; Tupasi et al., 2016; Walker et al., 2011).
Recruitment and retention are the cornerstones for research and often retention is less
emphasized than recruitment. Literature review of retention strategies used in studies (Booker,
Harding, & Benzeval, 2011; Bower et al., 2014; Butler et al., 2013; Hunt & White, 1998; Nicholson
et al., 2011; Steinhauser et al., 2006; Tansey, Matte, Needham, & Herridge, 2007; Wijk, 2014) can
mainly be categorized into 1) incentives to participants (Monetary and non-monetary), 2) frequent
communications with participants which include sending reminder appointment letters, conveying
research findings to participants and establishing trusting relationship with participants, 3) participant
convenience, e.g. flexibility in scheduling appointments, and 4) participant contact, which includes
frequent updating of participant contact information.
Most of the literature on participant retention is based on “lessons learned” and “what we used”
and is mostly focused on “clinical trials” and not observational studies (Booker et al., 2011; Bower et
al., 2014; Butler et al., 2013; Hunt & White, 1998; Steinhauser et al., 2006; Tansey et al., 2007; Wijk,
2014). Clinical trials differ from observational studies in that most trials offer potential direct benefit
to the participant, e.g., free drugs, laboratory and other tests, clinical evaluations, and possibly a cure.
Observational studies generally do not offer these benefits, instead, they often involve lengthy office
visits, questionnaires to be answered, and blood draws.
Though there are many published studies that discussed the strategies that were employed to
retain participants in a study, few studies actually asked the participants if the adopted strategies
facilitated their continued participation in the study and what factors motivated them to remain in a
longitudinal study.
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Chapter 2: Background
University of Michigan has been participating in a National Institutes of Health (NIH) funded
prospective observational study–the Hepatitis B Research Network (HBRN) Cohort Study since
2010. This study includes 21 adult clinical sites across the United States and in Toronto, Canada. 1
The investigators developed the study protocols and the Data Coordinating Center developed the
electronic database and Manual of Procedures. Study coordinators were trained on the conduct of the
study.
The HBRN Cohort study enrolls patients who meet the following criteria:
Inclusion criteria.
1. At least 18 years of age
2. Hepatitis B infection as determined by presence of hepatitis B surface antigen in the
serum
Exclusion criteria.
1. History of hepatic decompensation based on clinical or laboratory criteria
2. Hepatocellular carcinoma (HCC)
3. History of solid organ transplantation or bone marrow transplantation
4. Current hepatitis B antiviral treatment
5. Chronic immunosuppression therapy
6. Known HIV co-infection
7. Medical or social condition which, in the opinion of the investigator, would make the
patient unsuitable for the study or interfere with or prevent follow up per protocol.

1

Information regarding the HBRN Cohort study and the study design information was directly extracted from
HBRN Cohort study protocol. The official Study website is http://www.hepbnet.org/ . Anna SF Lok, MD, is the
consortium chair and principal investigator for the study at University of Michigan; she can be contacted at
aslok@med.umich.edu .
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8. Unable or unwilling to return for follow-up visits
The Objectives of the Study:
Primary Aim.
•

To describe participants with hepatitis B virus (HBV) infection in a prospective cohort in
the United States (US) and Canada and identify predictors of disease activation and
progression
Secondary Aims.

•

To describe clinical, virological, and immunological characteristics of participants with
HBV in the U.S. and Canada

•

To evaluate changes in HBV infection status and quantitative HBsAg levels and factors
associated with those changes

•

To develop a bank of bio specimens (e.g., serum, plasma, DNA, lymphocytes, liver
tissue) obtained from participants with HBV infection

•

To identify participants with HBV infection who are potential candidates in one of the
treatment studies to be conducted by HBRN

•

To describe the natural history of hepatitis B infection in pregnancy

The HBRN Cohort Study is a prospective observational study in which participants receive
standard of care that is billed to their health care insurance and clinical data (including laboratory,
radiology, and histology results) are collected for the research. Participants are required to undergo a
baseline evaluation and follow-up visits at Week 12, 24, 48, and every 24 weeks thereafter.
Baseline visit takes about two hours for
•

reviewing the consent with the patient and consenting the patient;
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•

questionnaires on health behavior, symptoms, and quality of life (SF-36) to be completed
by the participant;

•

collection of information on family history, past medical history, antiviral therapy for
HBV, and medication history; most likely source of the HBV infection, and the HBV
phenotype that best describes the participant;

•

brief physical examination;

•

blood drawn for laboratory tests related to hepatitis B and liver disease (10−16 ml);

•

blood drawn (with consent) to prepare and obtain serum or plasma for research testing
including genetic testing (about 45 ml).

Follow-up visits take about 45 minutes to complete and include
•

physical examination;

•

blood drawn for laboratory tests related to hepatitis B and liver disease (10−16ml);

•

interim history;

•

assessment for possible interim occurrence of any events related to disease
progression (e.g., cirrhosis, hepatic decompensation, HCC, or liver transplantation);

•

interim antiviral treatment and any changes in medications;

•

liver biopsy data (if one was performed for clinical indication);

•

for participants who consented, serum/plasma samples for research testing (24 ml at
annual visits and 20 ml at semiannual visits).

The study began enrolling in January 2011. Initially, the study was to continue for 6 years, but
NIH recently extended the funding period and maximum follow-up may be up to 10 years. While a
longer follow-up period will increase the number of events and the power of the data analysis, a
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major concern of the NIH, the Data and Safety Monitoring Board, and the investigators is the validity
of the data due to participant attrition over time.
The current retention rate in this cohort at University of Michigan is 86.6 % while the overall
retention rate is 75.7%. The major reasons for disenrollment are shown in Table 1 and University of
Michigan retention strategies are shown in Table 2.
Table 1
Reasons for Disenrollment
University of Michigan

Overall HBRN Cohort

No. of participants consented
(as of 5/2/16)

119

2015

No. of participants disenrolled
(as of 5/2/16)

16 (13.4%)

490 (24.3%)

Withdrew Consent

2 (12.5%)

152 (31.0%)

Relocation to cities/states
outside HBRN study sites

6 (37.5%)

87 (17.8%)

Lost to follow-up

4 (25%)

149 (30.4%)

Non-compliant with the
protocol

0

48 (9.8%)

Ineligible patient enrolled

0

4 (0.8%)

Screen failures (HBsAg
negative at baseline)

4 (25%)

21 (4.3%)

Other

0

29 (5.9%)

Reasons for disenrollment:
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Table 2
Retention Strategies Employed at University Of Michigan
Category
Strategies used since inception of study
Provide $25 subject fee at each visit on same day of visit
Incentive
Eliminate Co-pay for the visit (Clinic visit and research visit are
combined) [NB co-pay for tests not eliminated]
Use patient care dollars to cover co-pays of tests when the participant
has a lapse between health insurance coverage or high co-pays for tests
Patient convenience Combining clinic visits with research visits to avoid multiple visits to
the hospital
Flexibility in scheduling appointments (more options of days and times)
and options to reschedule with less hassles
Scheduling next appointment at their current visit and giving
participants time to plan ahead
Scheduling multiple appointments on the same day (e.g., ultrasound and
study visit)
Access to specialists with no wait or minimal wait as a part of the study
If participant cannot make it to the clinic within the protocol window,
they were encouraged to get local labs drawn and to complete the
questionnaire at home and sent back to study site.
Overall experience Visits are shorter and more efficient when compared to clinic (e.g., on
site blood draw with no wait time)
for the visit
Same staff at each visit helps build relationship
Complimentary refreshments at each visit, especially after a fasting
blood draw
Participant contact Updating participant information (Addresses, phone numbers &
insurances) at least yearly
Collecting participant alternative contact information
Asking what is the best mode of contact (email, phone, regular mail) and
noting participant preferences
Sending reminder appointment letters at least 2 weeks ahead of time
with date, time and location of visit.
Encouraging participants to communicate and ask questions and to
Communication
alert study staff with any changes to medications, health conditions,
etc.
Bi-yearly newsletters are sent to participants on what’s happening in
the study, what we have learned so far from the information collected
and some educational articles with regard to the disease and brief
overview of published papers from the study
Providing a direct phone number and email for participants to contact
study team and prompt response to questions and requests for changes
in appointment
Follow-up email or phone call is made to communicate results to the
participant after each visit.
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The HBRN study has a Recruitment and Retention committee that oversees recruitment and
retention and develops policies to improve these processes. Recently, the committee was charged to
examine the practices for participant retention adopted at each site with the goal of identifying best
practices that can be shared across the network.
I have been involved in the HBRN Adult Cohort Study since the beginning of the study and have
been the primary study coordinator at the University of Michigan site since August 2010. Although
our retention rate is higher than the overall retention rate for the entire network, I decided to conduct
a survey of our participants to understand what motivates them to stay in the study and what more
can we do to facilitate their continued participation in the study.
The aims of this retention survey study are as follows:
1) To determine HBRN Cohort Study participants’ evaluation of the University of
Michigan retention strategies
2) To identify other strategies that will improve retention rate among HBRN Cohort Study
participants at the University of Michigan
3) To develop best practices for retention in the HBRN Cohort Study that can be shared
with other sites
Clinical Significance:
Results of this study will provide us an insight on what motivates participants to stay in a longterm observational study and what can be done to further improve participants’ experience in
observational studies and thereby their retention in these studies. Our findings will help us retain
HBRN participants in the remaining 4 years of this study and will be shared with other sites in HBRN
such that overall retention can be improved.
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Chapter 3: Methodology
The study was designed to ask our participants in HBRN cohort study to evaluate the strategies
we at University of Michigan employ for participant retention and to identify other strategies that
may improve retention rates in the HBRN Cohort study at University of Michigan. To meet these
research goals, a questionnaire was developed drawing on surveys used in similar studies previously
published.
Study Population
University of Michigan HBRN cohort study enrolled 119 participants between January 2011 and Nov
2015. Over a period of 6 years, 2 participants have transferred to a different site within the network, 2
participants have died, and 16 participants were disenrolled from the study for various reasons as
noted in table 1. Thus, we are actively following 99 participants in the study.
Exclusion Criteria
Non-English speaking participants.Of the 99 participants actively followed, four are non-English
speaking, and the survey was administered to 95 participants.
Research Design
Pre-Study Phase.
•

Reviewed literature on patient recruitment and retention.

•

Designed study, questionnaire, informed consent, and intervention plan.

•

Obtained approval from thesis committee.

•

Obtained approval of the study from University of Michigan IRBMED & EMU’s
University Human Subjects Review Committee (UHSRC)
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Study Phase.
Survey. The survey included demographic information and questions to capture patient’s affinity to
participate in research, their motivation and demotivation to participate in the HBRN Cohort study,
and the likelihood they will stay in the study, which is expected to continue until late 2019.
Conduct of survey. Permission to conduct this survey was obtained from University of Michigan IRB
(Appendix A) and EMU’s UHSRC (Appendix B). The study was deemed exempt by both IRB under
EXEMPTION #2 of the 45 CFR 46.101.(b):Research involving the use of educational tests
(cognitive, diagnostic, aptitude, achievement), survey procedures, interview procedures or observation
of public behavior, unless: (i) information obtained is recorded in such a manner that human subjects
can be identified, directly or through identifiers linked to the subjects; and (ii) any disclosure of the
human subjects' responses outside the research could reasonably place the subjects at risk of criminal
or civil liability or be damaging to the subjects' financial standing, employability, or reputation.
While waiting for the study approval, the survey questionnaire was created in Qualtrics and
tested for compatibility to complete the survey on tablet, smart phone, and computer (laptop or
desktop).
Following IRB approval from both University Of Michigan and EMU, eligible participants were
identified from our HBRN database, and I called all the actively followed participants to determine if
they are interested to participate in the study. Survey was rolled out on June 23, rd 2016 and was open
for a month. Participants who provided verbal consent over the phone were provided the option of
either completing the survey online or by regular mail. Participants who had scheduled visits during
the survey period and who consented completed the survey during the study visit. For participants
who preferred to complete the written (paper and pencil) survey, survey questionnaire was sent via
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mail and pre-addressed stamped envelope was provided to return the survey. For participants who
preferred to answer the questions online, a link to the survey was sent to the participant via an email.
The UHSRC and IRBMED approved Appendices C, D & E to be used as introductions to the
survey questionnaire as appropriate. The survey introductions briefly described the purpose of the
study, study procedures, patients’ rights, and study team contact information and invitation to
participate.
Survey
Survey questionnaire (Appendix F) was used as the main and primary data gathering source for
this study. The survey included seven demographic questions, seven questions on patient’s affinity to
participate in research studies, 13 questions on motivation to continue participation, four questions on
demotivators to continue participation, and four questions to capture participants’ response whether
they would stay in the study untill the end, main reason they would discontinue participation, other
suggestions, and comments for the study team. Most of the questions were multiple choice questions
with some being open ended.
Motivation to participate. Participants were asked to rate retention strategies employed at the
University Of Michigan for the HBRN cohort study as motivators to continue participation in the
study using a 5- point Likert scale with a score of 1 being “completely disagree” to 5 being
“completely agree”. One additional question was asked to elicit the most important motivating factor
to stay in the study.
Demotivators to continue participation. Four questions were asked what the participants think
are major demotivators for staying in the study, and responses were recorded on a 5-point Likert scale
with a score of 1 being “completely Disagree” to 5 being “completely agree”.
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Likelihood of staying in the study. Participants answered one question on how likely they would
stay in the study that is expected to end in late 2019 on a 5-point Likert scale with 1 being “extremely
likely” to 5 being “extremely unlikely”. They were also asked to answer multiple choice questions on
what would be the major reasons for them to discontinue participation.
Lastly, two open-ended questions were asked to seek any recommendation to further improve the
experience of the research visits and to address any concerns.
Data Management and Analysis
Four weeks after the survey was sent out, the study was closed and the study data analysis phase
began. Responses of hard copy surveys were entered into Qualtrics so data from all participants can
be combined for analysis. To preserve anonymity, the survey database did not collect any information
or data (such as Internet protocol (IP) addresses) that might identify participants. Answers originally
obtained on 5-point Likert scale were later condensed to three categories, i.e., from completely agree,
agree, neutral, disagree, and completely disagree to agree, neutral and disagree. Similarly, the options
extremely unlikely, unlikely, neutral, likely, and extremely likely were condensed to unlikely,
neutral, and likely. Data were analyzed using Tableau Desktop version 9.3.
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Chapter 4: Results and Discussion
A total of 90 participants out of 95 invited responded to the survey for a response rate of
94.7%. The response rate is much higher than usual survey studies as we were surveying a familiar
population who has been under our care since 2011. Table 3 shows the response rates for each
method of survey administration. The response rate ranged from 100% for participants approached
in person in the clinic to 87.5% for those who chose to return hard copy (paper and pencil) survey
by mail.
Table 3
Methods of survey administration and response rate
Method of Survey
Number sent
Number returned

Response Rate

Administration
Mail survey

8

7

87.5%

In-person/At-visit

10

10

100%

77

73

94.8%

Survey
Electronic Survey via
Qualtrics

Four participants who completed less than 25% of the questions were excluded from data
analysis. Thus, data from 86 participants were analyzed.
Demographics
The demographic characteristics of the participants are summarized in Table 04. Participants
were a good mix of male (51.2%) and female (46.5%), and mostly non-Hispanic. Half of the
participants were between the ages of 40−60 years, median age was 46±13 years and range was 20
to 79 years. Half (50.2%) of the participants were Asian Chinese followed by White (22.4%) and

WHAT MOTIVATES PATIENTS TO REMAIN IN LONGITUDINAL OBSERVATIONAL
STUDIES?
14

Asian, non-Chinese (18%). Slightly over half (54.7%) of the participants had some graduate
school or professional degree training, and only 10.5% participants had high school education or
less. Almost half (45.4%) of the participants had annual income of more than $100,000 while
18.6% had annual income ≤ $50,000. All the participants had medical insurance with the majority
(87.2%) having private medical insurance and the remainder had Government medical insurance
(Medicare and Medicaid).
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Table 4
Demographic characteristics of Survey participants
Characteristic

Number
(N=86)

Percent

Gender
Female
Male
Not Answered

40
44
2

46.5%
51.2%
2.3%

Age
20-40 years
40-60 years
60-80 years

26
43
17

30.2%
50.0%
19.8%

Ethnicity
Hispanic or Latino
Not Hispanic or Latino
Not Answered

3
78
5

3.5%
90.7%
5.8%

Race
Asian, Chinese
Asian, non-Chinese
Black or African American
White
Other

38
17
5
22
4

50.2%
18.0%
5.7%
22.4%
3.7%

9
30

10.5%
34.9%

Education
High school graduate or less
Some college & College graduate
Some graduate school & Graduate
o /professional Degree
Income
Less than $50,000
$50,001- $100,000
Greater than $100,000
Not Answered/Unknown
Insurance
Government medical insurance (for
example: Medicare, Medicaid)
Private medical insurance (for
example: HMO, PPO, Blue Cross)

47

54.7%

16
23
39
8

18.6%
26.7%
45.4%
9.3%

11

12.8%

75

87.2%
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Affinity to Participate in Research Studies
Most (82.6%) of the participants reported they had not participated in any other research
studies previously and HBRN cohort study was the first research study that they ever participated
in.
Biggest Motivation to Sign up for the HBRN Study
Half (52.3%) of the participants reported that the biggest motivation to sign up for the study is
to help future patients in their situation, followed by perception they would get better care by
participating in the study (36.1%) as shown in Figure1.

This study might be able to help…

52.3%

I can get better care through this study

36.1%

My liver doctor asked me to

8.1%

Other(Please specify)

2.3%

It is an interesting study

1.2%
0%

Figure 1.Motivation to sign up for HBRN study

10% 20% 30% 40% 50%
Percentage of participants

60%
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Number of Years in HBRN study:
Participants had been followed in HBRN cohort study for a mean of 4.0±1.7 years with a
range of 1−6 years as shown in Figure 2.
3.5%

22.1%

52.3%
22.1%

2-5 years

> 5 years

< 2 years

Not Answered

Figure 2. Distribution of duration of participation in the HBRN Cohort Study
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Missed Visits and Reasons for Missed Visits
Nineteen (22.1%) participants reported, they had missed at least one visit during their
participation in the HBRN cohort study; of these, 8 missed only one visit and 2 missed three or
more visits.
The major reasons for missing visits were participants forgot their appointment (36.8%) and
out of town/country at the time of the scheduled visit (15.8%). Other reasons included appointment
was not at a convenient time, participant did not have a ride, and participant did not have time, or
had conflicting family commitments as mentioned in Figure 3.

I forgot the appointment

36.84%

I was out of town/country
at that visit window

15.79%

Other (Please Specify)

10.53%

Didn’t have time/ family
commitments

10.53%

Didn’t have a ride

10.53%

Appointment was not at
a convenient time

10.53%

Weather didn’t permit

5.26%
0%

Figure 3.Reasons for missed visits

10%
20%
30%
Percentage of participants

40%
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Co-pay at Each Visit
Thirty-six (41.9%) participants reported they had copay at each visit, with 20%(7)of
those who responded to the question on amount of copay at each visit indicating that the amount
per visit was $51−100 and 22% indicating that the amount was more than $100 per visit (as shown
in Figure 4).

8.3%
25.0%
19.4%

22.2%

$21-50

Not Answered

25.0%

Greater than $100

$51-100

less than $20

Figure 4.Distribution of co-pay at each visit among the 36 participants who had co-pay
requirement
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Motivators to Continue Participation in the HBRN Cohort Study
Retention strategies employed at University of Michigan were categorized into 1) incentives,
2) convenience of the visits, 3) overall experience of the visits, 4)patient contact, and 5)
communications. Participants were asked if they agreed that the strategies we employ at our site
were motivators for their continued participation in the HBRN cohort study. Convenience, overall
experience, frequent contacts, and communications with the study team were rated to be more
important than incentives for continued participation in HBRN cohort study. For those who agreed
financial incentives were important motivators, waiving co-pay (38.4%) was more important than
financial compensation (subject fee; 18.6%) at each visit (as noted in Table 5). When asked, which
is the most important motivator for continued participation in the HBRN cohort study, 41.9%
indicated overall experience of participating in the study, and 37.2% indicated gaining knowledge
about their disease, and 10.5% indicated ease of communications with the study team(as shown in
Figure 5).
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Table 5
Response of participants to questions on Motivators to continue participation in the HBRN
Cohort study
Not
Agree

Neutral

Disagree Answered

Compensation (money paid) at each visit

18.6%

33.7%

44.2%

3.5%

No copay to see the specialist

38.4%

27.9%

30.2%

3.5%

65.1%

19.8%

11.6%

3.5%

52.3%

32.6%

11.6%

3.5%

visits in regular clinic

64.0%

24.4%

8.1%

3.5%

I feel that I am better cared for in research

62.8%

24.4%

9.3%

3.5%

The research team are experts in my disease

84.9%

9.3%

2.3%

3.5%

76.7%

16.3%

3.5%

3.5%

80.2%

14.0%

2.3%

3.5%

75.6%

16.3%

4.7%

3.5%

participation in the study

77.9%

11.6%

7.0%

3.5%

The staff is easy to reach and answers my questions
promptly

82.6%

11.6%

2.3%

3.5%

Incentive

Convenience of the visits
It is easy to schedule and to reschedule my appointments,
and they work with my calendar and are flexible
Overall experience for a visit
Doctors spend more time with me in research visit than
they would in clinic
I feel research environment is more relaxed compared to

Visits are more efficient, with minimal wait times, and
blood draw is in the same place
Patient contact
Study staff knows the best way to reach me and respects
my preferences on how to be contacted
The appointment reminder letters help me keep or
reschedule my appointment

Communication
I am learning more about the disease since my

Results expressed as percent of participants
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Overall experience of the visit

41.9%

Information regarding the disease

37.2%

Communication (ease of…

10.5%

Subject fee(Money paid) for each visit

3.5%

Not Answered

3.5%

Convenience of the visits

3.5%
0%

10%
20%
30%
40%
Percentage of participants

50%

Figure 5.Main motivator to continue participation in the study
Demotivators to Continue Participation in the HBRN Study
When participants were asked whether certain aspects of the study such as need for
fasting, amount of blood drawn, amount of questionnaire to be completed, and not receiving
treatment bothered them, majority (around 65%) disagreed (Table 6).
Table 6
Responses of participants to questions on demotivators to continue participation in the HBRN
Cohort study
Not
Agree
8 hours of fasting at annual visits bothers me
The amount of blood drawn at each visit for research
purposes bothers me
The amount of questionnaires to be completed for
research at each visit bothers me
The concept of just being observed and not getting
any treatment bothers me

Neutral

Disagree swered

10.5%

20.9%

67.4%

1.2%

9.3%

23.3%

66.3%

1.2%

10.5%

24.4%

64.0%

1.2%

10.5%

23.3%

65.1%

1.2%
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Likelihood of Staying in the HBRN Cohort Study
The vast majority (88.4%) of participants responded they are likely to stay in the study that
is currently projected to end in late 2019, 7% were neutral, and only 2.3% said no (Figure 6).
2.3% 2.3%
7.0%

88.4%

Likely

Neutral

Unlikely

Not Answered

Figure 6. Distribution or participants’ response regarding likelihood of staying in the HBRN
Cohort Study
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Main Reasons for Discontinuation in HBRN Cohort Study:
When participants were asked what would be their main reason to discontinue participating in
HBRN cohort study, the most common reason (59.3%) was if they were to move away from the
study site followed by loss of insurance or high co-pay (17.5%) as shown in Figure 7.
7.0%
8.1%
8.1%

59.3%
17.5%

Moving away from study site

Loss of insurance / high copay’s

No time /family commitments

other (Please Specify)

Not Answered
Figure 7.Possible reasons that may lead to withdrawal from the HBRN Cohort study
Comments from Participants. When participants were asked to provide suggestions for
additional strategies that would help them stay in the study, only 33 (38.37%) responded, 15
of whom indicated no changes needed, 10 would like to have financial assistance, and 4
would like to be seen in satellite research clinics closer to their homes (as noted in Table 7).
Participants were asked to provide additional written comments towards the end of the survey.
Twenty-two (25.58%) did so, of these 9 participants expressed their gratitude towards the
study team and/or for the opportunity to participate, 5 expressed appreciations for the study
team and 4 had other suggestions for us (as noted in Table 8).
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Table 7
Comments from participants on what more can be provided to help them stay in the study
Comments from the patients

Count (n=33)

No changes Desired
Nothing

9

Continue as is

4

Study team is doing its best

2

Total

15

Cover Co-pays

6

More Compensation

1

Food Vouchers

1

Treatment if needed

1

Low priced Drug

1

Total

10

Financial Assistance

4

Satellite research clinics
Total

4

Provide Study results

1

No wait time

1

Transparency on which physician is seeing me

1

Provide efficient Phlebotomists

1

Total

4

Other

WHAT MOTIVATES PATIENTS TO REMAIN IN LONGITUDINAL OBSERVATIONAL
STUDIES?
26

Table 8
Other comments from the study Participants
Count
=22)

Other Comments From Participants
Gratitude
Appreciate being part of the study
Thank you for caring/Receiving Proper Care
Thank you for studying a disease that has been somewhat
forgotten
Happy to help
Total
Appreciation For The Study Team

2
3
1
3
9
5

Other
Provide More information regarding disease
Invent Cure
Provide study results on Regular basis
Research coordinator discusses results
Total

1
1
1
1
4

A major goal for this survey study is to identify strategies to improve retention in the
HBRN cohort study and to share best practice with other sites. Although most (88.4%) of our
participants responded that they are likely to complete the study that is projected to end in late
2019, 10 participants (11.6%) have either not responded to the question, said that they are neutral
or they are unlikely to complete the study. Characteristics of these 10 participants are similar to
those who indicated they are likely to stay in the study (Table 9). A higher percent of participants
who had been in the HBRN study for longer than 2 years indicated they are likely to stay in the
study than those who joined the study more recently.
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Table 9
Characteristics of participants who are likely vs. those who are unlikely to stay in the study

Characteristic

Likely
Number Percent

Neutral, Not Answered,
Unlikely
Number
Percent

Gender
Female
Male
Not Answered

36
38
2

47.37%
50.00%
2.63%

4
6

40.00%
60.00%

Age groups
20-40 yrs
40-60 yrs
60-80 yrs

23
38
15

30.26%
50.00%
19.74%

3
5
2

30.00%
50.00%
20.00%

Ethnicity
Hispanic or Latino
Not Hispanic or Latino
Not Answered

2
69
5

2.63%
90.79%
6.58%

1
9

10.00%
90.00%

Race
Asian, Chinese
Asian, non-Chinese
Black or African American
Other
White

36
15
4
3
18

47.37%
19.74%
5.26%
3.95%
23.68%

2
2
1
1
4

20.00%
20.00%
10.00%
10.00%
40.00%

8
28

10.53%
36.84%

1
2

10.00%
20.00%

40

52.63%

7

70.00%

Total household income ($) per year
Less than $50,000
$50,001- $100,000
Greater than $100,000
Not Answered/ Unknown

15
20
35
6

19.74%
26.32%
46.05%
7.89%

1
3
4
2

10.00%
30.00%
40.00%
20.00%

Health insurance status
Government medical insurance
Private medical insurance

10
66

13.16%
86.84%

1
9

10.00%
90.00%

Highest level of school you attended
High school graduate or less
Some college & College graduate
Some graduate school & Graduate /
professional Degree
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Table 9 (continued)

Number of years in the study
< 2 years
>=2 years
Not answered

14
60
2

18.42%
78.94%
2.63%

5
4
1

50.00%
40.00%
10.00%

To understand which participants are more likely to have missed study visits, characteristics
of the participants who reported having missed at least one visit in the HBRN cohort study were
compared to those who reported they had never missed a visit. (Table 10, Figure 8). Younger age
was the most important factor associated with having missed a visit.
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Table 10
Comparison of participants with vs. without missed visits in the HBRN

Characteristic
Gender
Female
Male
Not Answered

No
Number Percent

Yes
Number Percent

29
38

43.3%
56.7%

11
6
2

57.9%
31.6%
10.5%

Age groups
20-40 years
40-60 years
60-80 years

18
33
16

26.9%
49.3%
23.9%

8
10
1

42.1%
52.6%
5.3%

Ethnicity
Hispanic or Latino
Not Hispanic or Latino
Not Answered

2
63
2

3.0%
94.0%
3.0%

1
15
3

5.3%
79.0%
15.8%

Race
Asian, Chinese
Asian, non-Chinese
Black or African American
Other
White

31
13
2
3
18

46.3%
19.4%
3.0%
4.5%
26.9%

7
4
3
1
4

36.8%
21.1%
15.8%
5.3%
21.1%

8
24

11.9%
35.8%

1
6

5.3%
31.6%

35

52.2%

12

63.2%

Total household income ($) per year
Less than $50,000
$50,001- $100,000
Greater than $100,000
Not Answered/ Unknown

13
19
29
6

19.4%
28.4%
43.3%
9.0%

3
4
10
2

15.8%
21.1%
52.6%
10.5%

Health insurance status
Government medical insurance
Private medical insurance

10
57

14.9%
85.1%

1
18

5.3%
94.7%

Highest level of school you attended
High school graduate or less
Some college & College graduate
Some graduate school & Graduate / Professional
degree
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Discussion
The goals of this survey study are to determine HBRN Cohort Study participants’
evaluation of the University of Michigan retention strategies, to identify other strategies that will
improve retention rate among HBRN Cohort Study participants at University of Michigan and to
develop best practices for retention in the HBRN Cohort Study that can be shared with other sites.
Our response rate of 94.7% was much higher than most survey studies likely related to our
long relationship with the participants and multiple modalities of completing the survey (hard copy
in person at study visit, by return mail, or electronic link via email).
Our study population differs from the general population in the U.S. in having a high
proportion of Asians, with high education level, and high income, and 100% having some form of
health insurance. In the United States, the prevalence of chronic hepatitis B is low in the general
population but 10-fold higher among Asians thus explaining the high proportion of Asians in this
survey study (Roberts et al., 2016). The high education level and high income level among our
participants might be related to the location of our study site in a college town. Because the HBRN
cohort study is an observational study with standard of care testing billed to participant insurance,
it is not surprising that 100% of our participants have some form of health insurance.
Although the HBRN Cohort Study is an observational study we conducted study visits at
our clinical research unit instead of the regular clinic. The clinical research unit differs from the
regular clinic in that the unit is equipped with a lab, and staffed by specially trained nurses and
medical assistants in addition to the HBRN research team. This set-up allows efficient evaluation
of participants, and blood draw and sample processing at the same location. The spacious facility
also provides a more relaxed environment for participants and ample private space for completion
of questionnaire.
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Our unique set-up may explain why the retention rate at our site is substantially higher
than the overall retention rate of HBRN Cohort Study. In addition to the resources available
through the clinical research unit, we also adopted several strategies from inception of the study,
including emphasizing on investigator meeting the participants at each visit and having the same
study coordinator in charge of the study. This allows us to build a strong relationship with the
participants. We also adopt many strategies to optimize communications and to facilitate
scheduling and rescheduling of study visits including flexibility in scheduling appointments,
sending reminder letters, planning future visits in advance, responding to participants’ questions
and concerns promptly, and checking for changes in participants’ contact information at each visit.
Finally, the principal investigator who is a world renowned expert in hepatitis B and a native
Chinese who can speak Chinese is on hand to evaluate the participants at more than 50% of the
study visits and provides updates on hepatitis B and the study to the participants. Indeed, the
overall experience of study visits was the most important reason why participants remain in the
study whereas financial incentive was a minor factor. However, co-pays remained a hurdle for
some participants. Although we do not charge (neither insurance carrier nor participant) for the
office visits, blood tests are performed at each visit for all participants and ultrasounds for a
subgroup of participants. Almost half of our participants reported they had co-pays for these tests
that can exceed $100 per visit though similar copays would be required if the participants were
monitored in clinical practice. We have tried to mitigate this by covering tests for participants who
have temporary lapse in their insurance or when participants have unusually high co-pays. In
addition, we refer participants to social services to help their financial situation when appropriate.
For participants whose insurance changed during the study and their new insurance makes us out
of network, we work with participants’ primary care physician to order the labs and get them
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drawn locally. Elimination of co-pays was more important for our participants than the $25 subject
fee which we offer after completing each visit; whether responses would be different if a higher
amount of subject fee is provided is unclear. Overall experience of the study visits and provision
of information regarding the disease were the two most important motivating factors for continued
participation in the HBRN cohort study. Compared to clinical trials, observational studies do not
offer free medications or testing instead observational studies involve lengthy office visits,
multiple questionnaires to be answered, and blood draws for research with no direct benefit to the
participants. Nevertheless, only 10% of our participants were bothered by these study procedures.
Clearly explaining the purpose of the study, visits and procedures required, and risks and benefits
upfront minimize participant resent or regret after consenting. Half of our participants responded
that they signed up for the study to help future patients with the same disease and not for their own
personal gain.
Although only 11% of our participants may not stay until the end of the study,
understanding participants’ concerns and removing those barriers are important to maximize
retention.
Strategies that can be implemented to maintain and to improve retention rate at our
site. Overall experience at the study visit is the most important motivator our participants stay in
the study, and we will strive to maintain the quality of this experience. In addition, based on the
survey results we will implement several new strategies to enhance that experience. These include
the following:
1) Provide flow sheet with serial test results and study newsletter to participants when
they check-in.This strategy will encourage participants to review their past results
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and to read the newsletter and stimulate them to ask more questions and have a
better understanding of their disease and the study.
2) Continue to mail reminder appointment letters to all participants 2 weeks before
appointment and to add phone or email reminder to participants 1−2 days before
the scheduled visit date.
3) Review patient care study budget and determine whether it is possible to cover or
waive co-pays for participants with high co-pays or financial hardship.
Best practices for retention in the HBRN cohort study. Though having a dedicated research
clinic may not be feasible for every site involved in the study, several of the strategies that work
well for our site can be easily implemented at other sites where participants are seen in clinics by
multiple providers who may not be part of the research team:
1) Informing participants who they will be seeing at the next visit and having the same
study coordinator seeing participants at each visit will help develop strong
relationship with patients.
2) If participants raise concerns about high co-pays, evaluating if some tests can be
deferred to the next visit or done locally.
3) When ordering labs, reviewing the labs ordered with participants to reassure them
the tests are required labs for monitoring their health and not just for research.
4) If participants relocate, transfer cares to another HBRN site if possible, if not,
encourage the participants to participate remotely. Even though the participant can’t
be physically seen and the study would be missing physical exam information and
research bloods, it is still possible to capture useful data such as labs, progression of
liver disease, and initiation or discontinuation of treatment for hepatitis B.
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5) Review study visit window and compare to scheduled clinic follow-up appointment
and work with the clinical team to minimize missed visits.
6) Remind patients of their upcoming follow-up clinic visits and remind them they will
also be seen for the study.
7) Provide study coordinators phone number for easy access, facilitate communications
with clinical team, and respond to questions related to the research study promptly.
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Chapter 5: Conclusion
Providing a pleasant experience to the participants at each visit, engaging in good
communication with participants, establishing a strong trusting patient-doctor relationship,
minimizing turnover of staff, using specialized phlebotomists for blood draw, decreasing wait time at
the visits, and providing information about their health and progress of the study are motivating
factors important to our participants. Though incentives (monetary and non-monetary) are not
important to most participants, a substantial proportion would like to see decrease or waiving of copays but implementation will be difficult due to budget constraints. Having a physician that is expert
in their disease and a familiar study team is a very good motivating factor for participants to come
back. Study teams should also identify participants that frequently miss their visits and put special
efforts in retaining these participants. These study results will be shared with the entire network with
the goal of improving retention at all sites.
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Appendix A: University Of Michigan IRBMED (Institutional Review Board) Notice of
Exemption
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Appendix B: University Human Subjects Review Committee (UHSRC) Notice of
Exemption
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Appendix C: Introduction to Survey through Qualtrics
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Appendix D: Introduction to Survey: In Person
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Appendix E: Introduction to Survey: By Mail
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Appendix F: Survey questions
Questionnaire:
Demographics:
What is you Gender? ___Male ___Female
How old are you? ____
Which best describes your race?
___ White
___ Black or African American

___ American Indian or Alaska Native
___ Native Hawaiian or Other Pacific

Islander
___ Asian, Chinese

___ Other

___ Asian, non-Chinese
Which best describes your ethnicity?
___ Hispanic or Latino

___ Not Hispanic or Latino

What is the highest level of school you attended?
___ Some high school or less

___ College graduate

___ High school graduate

___ Some graduate school

___ Some college

___ Graduate / Professional Degree

What is your total household income ($) per year?
___ Less than $25,000

___ $75,001-100,000

___ $25,001-50,000

___ More than $100,000

___ $50,001-75,000

___ Unknown
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Which of the following best describes your health insurance status? (May select more
than one)
___ I have government medical insurance (for example: Medicare, Medicaid)
___ I have private medical insurance (for example: HMO, PPO, Blue Cross)
___ I do not have medical insurance
Affinity to participate in research studies:
Have you participated in any other research studies (Other than the HBRN Cohort
study)?
___ Yes

___ No

What is your biggest motivation to participate in the HBRN study (Select One)?
___ I signed up because it is an interesting study
___ I signed up because this study might be able to help future patients in my situation.
___I signed up because I can get better care through this study
___I signed up because my liver doctor asked me to
___I signed up because of the compensation (money) for participation.
___Other reasons: __________
How long have you been participating in the HBRN study?

____ years

Have you missed any visits as part of the HBRN study? ___Yes ____No
If Yes,
How many visits have you missed? ____
What is the main reason for you to miss the visit/s?
___ I forgot the appointment
___ Appointment was not at a convenient time

WHAT MOTIVATES PATIENTS TO REMAIN IN LONGITUDINAL OBSERVATIONAL
STUDIES?
47

___ Weather didn’t permit
___ Didn’t have time/ family commitments
___ Didn’t have a ride
___ I was out of town/country at that visit window
___ I was dealing with other major health problem
___Other
If other , please Specify ___________________
What is the distance from your home to University of Michigan Hospital?
__________(approx. miles)

_________(driving time – minutes)

Do you have copays for the tests we order at each HBRN visit for standard of care
purposes?
___ Yes ___No
If Yes,
What is the average amount you pay per visit _____ (in USD)?
Are you currently receiving any treatment (Medication) for Hepatitis B? ___ Yes
___No
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Motivation to continue Participation
For each statement below related to your motivation to continue participation in the
HBRN Cohort study, please indicate how much you agree or disagree. Rate on Scale of 1
(completely Disagree) to 5(Completely Agree).Choose only One response for each statement.
Completely Somewhat Neutral
disagree
disagree
(3)
(1)
(2)

Somewhat Completel
agree
y agree
(4)
(5)

Incentive
Compensation(money paid) at each visit
tivates me to come back

1

2

3

4

5

No copay to see the specialist motivates
to come back

1

2

3

4

5

1

2

3

4

5

Visits are more efficient, with minimal
t times, and blood draw is in the same
ce

1

2

3

4

5

Doctors spend more time with me in
earch visit than they would in clinic

1

2

3

4

5

I feel research environment is more
axed compared to visits in Regular clinic

1

2

3

4

5

I feel that I am better cared for in
earch

1

2

3

4

5

The research team are experts in my
ease

1

2

3

4

5

Convenience of the visits

It is easy to schedule and to reschedule
appointments, and they work with my
endar and are flexible
Overall experience for the visit
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Patient contact
The appointment reminder letters help
to keep or reschedule my appointment.
Study staff knows the best way to reach
and respects my preferences on how to be
ntacted

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

Communication
The staff is easy to reach and answers
questions promptly
I am learning more about the disease
ce my participation in the study.

Which factor is most motivating for you to stay in the study? (Select one)
___ Subject fee for each visit
___ Convenience of the visits
___ Overall experience of the visit
___ Communication (ease of communication with study team)
___ Information regarding the disease
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Demotivators to continue Participation in observational studies like HBRN Cohort study
For each statement below related to your de-motivators to continue participation in the
HBRN Cohort study, please indicate how much you agree or disagree. Rate on Scale of 1
(completely Disagree) to 5(Completely Agree).Choose only One response for each statement.
Completely Somewhat Neutral
disagree
disagree
(3)
(1)
(2)

Somewhat Completely
agree
agree
(4)
(5)

8 hours of fasting at annual visits
hers me

1

2

3

4

5

The amount of blood drawn at each visit
research purposes bothers me

1

2

3

4

5

The amount of questionnaires to be
mpleted for research at each visit bothers

1

2

3

4

5

The concept of just being observed and
getting any treatment bothers me

1

2

3

4

5

Please answer the question below. Rate on Scale of 1 (Extremely unlikely) to 5
(Extremely likely). Choose only one response.
Extremely
nlikely (1)

How Likely will you stay in the study till the
d currently projected to be late 2019 ?

1

Unlikely
(2)

2

Neutral
(3)

3

likely
(4)

Extremely
likely
(5)

4

5
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If you were to discontinue participation in the study, what would be the main the
reason?

__ Moving away from study site
__ Loss of insurance / high copay’s
__ No time /family commitments
__ other

If other, Please Specify ___________________

What else can we do to facilitate your staying in the study?
___________________________________________________________

Other comments:

